
|Articles|November 15, 2003
Refractec files PMA for presbyopia procedure
Irvine, CA-Refractec Inc. has filed its pre-market approval application with the FDA for a conductive keratoplasty (CK) procedure designed for patients with presbyopia.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
2
First patient treated in ViaLase’s IDE trial
3
PainReform launches development plan for OcuRing-K, readies phase 2 trial
4
Avisi Technologies treats first patient in SAPPHIRE trial for glaucoma
5















































.png)


